Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Intra-Cellular Therapies
Pharma
Intra-Cellular moves closer to Caplyta depression expansion
With two positive data sets in hand, Intra-Cellular is waiting for a third readout by June to file for Caplyta in major depressive disorder.
Angus Liu
Apr 16, 2024 2:27pm
Intra-Cellular re-ups winning ad as bipolar drug builds momentum
Aug 8, 2023 12:51pm
Alnylam, Intra-Cellular among RBC's top picks for M&A
Apr 19, 2023 3:20pm
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
Intra-Cellular turns a light on bipolar in new Caplyta ad
May 9, 2022 7:33am
Intra-Cellular's Caplyta gains label expansion with bipolar nod
Dec 20, 2021 4:45pm